Iron metabolism and malaria

Food and Nutrition Bulletin

Volumn 28, Issue 4 SUPPL., 2007, Pages

  Prentice, Andrew M ^a,b   Ghattas, Hala ^a   Doherty, Conor ^b   Cox, Sharon E ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

Anemia; Erythropoiesis; Hemoglobin; Iron; Malaria; Supplementation

Indexed keywords

ANEMIA; CHILD HEALTH; CONFERENCE PROCEEDING; DISEASE TREATMENT; FOOD SUPPLEMENTATION; HOST-PATHOGEN INTERACTION; MALARIA; NUTRITIONAL STATUS; VITAMIN DEFICIENCY;

EID: 38549140628     PISSN: 03795721     EISSN: None     Source Type: Journal    
DOI: 10.1177/15648265070284s406     Document Type: Conference Paper

References (88)

1. WHO, UNICEF. Focusing on anaemia. Towards an integrated approach for effective anaemia control. Joint WHO/UNICEF Statement Geneva: Joint WHO/ UNICEF Statement, 2004.
2. Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr 2001;131:616S-33S; discussion 33S-35S.
3. Murray MJ, Murray AB, Murray NJ, Murray MB. Diet and cerebral malaria: the effect of famine and refeeding. Am J Clin Nutr 1978;31:57-61.
4. Nyakeriga AM, Troye-Blomberg M, Dorfman JR, Alexander ND, Back R, Kortok M, Chemtai AK, Marsh K, Williams TN. Iron deficiency and malaria among children living on the coast of Kenya. J Infect Dis 2004; 190:439-47.
5. Oppenheimer SJ, Macfarlane SB, Moody JB, Bunari O, Hendrickse RG. Effect of iron prophylaxis on morbidity due to infectious disease: report on clinical studies in Papua New Guinea. Trans R Soc Trop Med Hyg 1986; 80:596-602.
6. Shipton D. Association between haemoglobin level and susceptibility to malaria: a study of Gambian children [MSc dissertation]. London: London School of Hygiene and Tropical Medicine; 2004.
7. Snow RW, Byass P, Shenton FC, Greenwood BM. The relationship between anthropometric measurements and measurements of iron status and susceptibility to malaria in Gambian children. Trans R Soc Trop Med Hyg 1991;85-584-9.
8. Asobayire FS, Adou P, Davidsson L, Cook JD, Hurrell RE Prevalence of iron deficiency with and without concurrent anemia in population groups with high prevalences of malaria and other infections: a study in Cote d'Ivoire. Am J Clin Nutr 2001;74:776-82.
9. Allen SJ, O'Donnell A, Alexander ND, Alpers MP, Peto TE, Clegg JB, Weatherall DJ. alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci U S A 1997; 94:14736-41.
10. Murray MJ, Murray AB, Murray MB, Murray CJ. The adverse effect of iron repletion on the course of certain infections. Br Med J 1978;2:1113-5.
11. Smith AW, Hendrickse RG, Harrison C, Hayes RJ, Greenwood BM. The effects on malaria of treatment of iron-deficiency anaemia with oral iron in Gambian children. Ann Trop Paediatr 1989;9:17-23.
12. Oppenheimer SJ, Gibson FD, Macfarlane SB, Moody JB, Harrison C, Spencer A, Bunari O. Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua New Guinea. Trans R Soc Trop Med Hyg 1986;80:603-12.
13. Byles AB, D'sa A. Reduction of reaction due to iron dextran infusion using chloroquine. Br Med J 1970;3:625-7.
14. Berger J, Dyck JL, Galan P, Aplogan A, Schneider D, Traissac P, Hercberg S. Effect of daily iron supplementation on iron status, cell-mediated immunity, and incidence of infections in 6-36 month old Togolese children. Eur J Clin Nutr 2000;54:29-35.
15. Chippaux JP, Schneider D, Aplogan A, Dyck JL, Berger J. [Effects of iron supplementation on malaria infection]. Bull Soc Pathol Exot 1991;84:54-62.
16. Desai MR, Mei JV, Kariuki SK, Wannemuehler KA, Phillips-Howard PA, Nahlen BL, Kager PA, Vulule JM, ter Kuile FO, Randomized, controlled trial of daily iron supplementation and intermittent suffadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya. J Infect Dis 2003;187:658-66.
17. Nwanyanwu OC, Ziba C, Kazembe PN, Gamadzi G, Gandwe J, Redd SC. The effect of oral iron therapy during treatment for Plasmodium falciparum, malaria with sulphadoxine-pyrimethamine on Malawian children under 5 years of age. Ann Trop Med Parasitol 1996;90:589-95.
18. Verhoef H, West CE, Nzyuko SM, de Vogel S, van der Valk R, Wanga MA, Kuijsten A, Veenemans J, Kok FJ. Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet 2002;360:908-14.
19. van den Hombergh J, Dalderop E, Smit Y. Does iron therapy benefit children with severe malaria-associated anaemia? A clinical trial with 12 weeks supplementation of oral iron in young children from the Turiani Division, Tanzania. J Trop Pediatr 1996;42:220-7.
20. Lawless JW Latham MC, Stephenson LS, Kinoti SN, Pertet AM. Iron supplementation improves appetite and growth in anemic Kenyan primary school children. J Nutr 1994;124:645-54.
21. Mebrahtu T, Stoltzfus Rj, Chwaya HM, Jape JK, Savioli L, Montresor A, Albonico M, Tielsch JM. Low-dose daily iron supplementation for 12 months does not increase the prevalence of malarial infection or density of parasites in young Zanzibari children. J Nutr 2004;134:3037-41.
22. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, Font F, Acosta CJ, Schellenberg DM, Galindo CM, Kimario J, Urassa H, Brabin B, Smith TA, Kitua AY, Tanner M, Alonso PL. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997;350:844-50.
23. Menendez C, Todd J, Alonso PL, Francis N, Lulat S, Ceesay S, M'Boge B, Greenwood BM. The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria. Trans R Soc Trop Med Hyg 1994;88:590-3.
24. van Hensbroek MB, Morris-Jones S, Meisner S, Jaffar S, Bayo L, Dackour R, Phillips C, Greenwood BM, Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:672-6.
25. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK, Kabole FM. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006;367:133-43.
26. Harvey PW. Heywood PF, Nesheim MC, Galme K, Zegans M, Habicht JP, Stephenson LS, Radimer KL, Brabin B, Forsyth K, et al. The effect of iron therapy on malarial infection in Papua New Guinean schoolchildren. Am J Trop Med Hyg 1989;40:12-8.
27. Andrews NC. Iron homeostasis: insights from genetics and animal models. Nat Rev Genet 2000;1:208-17.
28. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature 2001;409: 198-201.
29. Wickramasinghe SN, Abdalla SH. Blood and bone marrow changes in malaria. Baillieres Best Pract Res Clin Haematol 2000;13:277-99.
30. Phillips RE, Looareesuwan S, Warrell DA, Lee SH, Karbwang J, Warrell MJ, White NJ, Swasdichai C, Weatherall DJ. The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med 1986;58:305-23.
31. Abdalla S, Weatherall DL Wickramasinghe SN, Hughes M. The anaemia of P. falciparum malaria. Br J Haematol 1980;46:171-83.
32. Sen R, Bhatnagar BM, Singh U, Yadav MS, Schgal PK. Patterns of erythropoiesis and anaemia in malaria. J Commun Dis 1990;22:247-53.
33. Srichaikul T, Wasanasomsithi M, Poshyachinda V, Panikbutr N, Rabieb T. Ferrokinetic studies and erythropoiesis in malaria. Arch Intern Med 1969;124:623-8.
34. Das BS, Thurnham DI, Das DB. Influence of malaria on markers of iron status in children: implications for interpreting iron status in malaria-endemic communities. Br J Nutr 1997;78:751-60.
35. Menendez C, Quinto LL, Kahigwa E, Alvarez L, Fernandez R, Gimenez N, Schellenberg D, Aponte JJ, Tanner M, Alonso PL. Effect of malaria on soluble transferrin receptor levels in Tanzanian infants. Am J Trop Med Hyg 2001;65:138-42.
36. Stoltzfus RJ, Chwaya HM, Montresor A, Albonico M, Savioli L, Tielsch JM. Malaria, hookworms and recent fever are related to anemia and iron status indicators in 0- to 5-y old Zanzibari children and these relationships change with age. J Nutr 2000;130:1724-33.
37. Stoltzfus RJ, Chwaya HM, Albonico M, Schulze KJ, Savioli L, Tielsch JM. Serum ferritin, erythrocyte protoporphyrin and hemoglobin are valid indicators of iron status of school children in a malaria-holoendemic population. J Nutr 1997;127:293-8.
38. Massaga JJ, Kitua AY, Lemnge MM, Akida JA, Malle LN, Ronn AM, Theander TG, Bygbjerg IC. Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. Lancet 2003;361:1853-60.
39. Verhoef H, West CE, Kraaijenhagen R, Nzyuko SM, King R, Mbandi MM, van Laatum S, Hogervorst R, Schep C, Kok FJ. Malarial anemia leads to adequately increased erythropoiesis in asymptomatic Kenyan children. Blood 2002;100:3489-94.
40. Stoltzfus RJ, Chway HM, Montresor A, Tielsch JM, Jape JK, Albonico M, Savioli L. Low dose daily iron supplementation improves iron status and appetite but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children. J Nutr 2004;134:348-56.
41. Kurtzhals JA, Addae MM, Akanmori BD, Dunyo S, Koram KA, Appawu MA, Nkrumah FK, Hviid L. Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren. Trans R Soc Trop Med Hyg 1999;93:623-7.
42. Loyevsky M, John C, Dickens B, Hu. V, Miller JH, Gordeuk VR. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators. Mol Biochem Parasitol 1999;101:43-59.
43. Scholl PF, Tripathi AK, Sullivan DJ. Bioavailable iron and heme metabolism in Plasmodium falciparum. Curr Top Microbiol Immunol 2005;295:293-324.
44. Darbari D, Loyevsky M, Gordeuk V, Kark JA, Castro O, Rana S, Apprey V, Kurantsin-Mills J. Fluorescence measurements of the labile iron pool of sickle erythrocytes. Blood 2003;102:357-64.
45. Ginsburg H. Iron acquisition by Plasmodium spp. Parasitol Today 1999;15:466.
46. Atamna H, Ginsburg H. Heme degradation in the presence of glutathione. A proposed mechanism to account for the high levels of non-heme iron found in the membranes of hemoglobinopathic red blood cells. J Biol Chem 1995;270:24876-83.
47. Gabay T, Ginsburg H. Hemoglobin denaturation and iron release in acidified red blood cell lysate - a possible source of iron for intraerythrocytic malaria parasites. Exp Parasitol 1993;77:261-72.
48. Iyer JK, Shi L, Shankar AH, Sullivan DJ, Jr. Zinc protoporphyrin IX binds heme crystals to inhibit the process of crystallization in Plasmodium falciparum. Mol Med 2003;9:175-82.
49. Cabantchik ZI, Moody-Haupt S, Gordeuk VR. Iron chelators as anti-infectives; malaria as a paradigm. FEMS Immunol Med Microbiol 1999;26:289-98.
50. Hershko C. Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelators. Baillieres Clin Haematol 1994;7:965-1000.
51. Pradines B, Tall A, Ramiandrasoa F, Spiegel A, Sokhna C, Fusai T, Mosnier J, Daries W, Trape JF, Kunesch G, Parzy D, Rogier C. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum. J Antimicrob Chemother 2006;57:1093-9.
52. Meshnick SR, Yang YZ, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother 1993;37:1108-14.
53. Golenser J, Domb A, Mordechai-Daniel T, Leshem B, Luty A, Kremsner P. Iron chelators: correlation between effects on Plasmodium spp. and immune functions. J Parasitol 2006;92:170-7.
54. Nyakeriga AM, Williams TN, Marsh K, Wambua S, Perlmann H, Perlmann P, Grandien A, Troye-Blomberg M. Cytokine mRNA expression and iron status in children living in a malaria endemic area. Scand J Immunol 2005;61:370-5.
55. Smith HJ, Meremikwu M. Iron chelating agents for treating malaria. Cochrane Database Syst Rev 2003:CD001474.
56. Weatherall DJ. The global problem of genetic disease. Ann Hum Biol 2005;32:117-22.
57. Williams TN, Maitland K, Bennett S, Ganczakowski M, Peto TE, Newbold CI, Bowden DK, Weatherall DJ, Clegg JB. High incidence of malaria in alpha-thalassaemic children. Nature 1996;383:522-5.
58. Rees DC, Williams TN, Maitland K, Clegg JB, Weatherall DJ. Alpha thalassaemia is associated with increased soluble transferrin receptor levels. Br J Haematol 1998;103:365-9.
59. Maitland K, Williams TN, Bennett S, Newbold CI, Peto TE, Viji J, Timothy R, Clegg JB, Weatherall DJ, Bowden DK. The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg 1996;90:614-20.
60. Weatherall DJ, Clegg JB. Genetic variability in response to infection: malaria and after. Genes Immun 2002; 3:331-7.
61. Parikh S, Dorsey G, Rosenthal PJ. Host polymorphisms and the incidence of malaria in Ugandan children. Am J Trop Med Hyg 2004;71:750-3.
62. Destro Bisol G. Genetic resistance to malaria, oxidative stress and hemoglobin oxidation. Parassitologia. 1999; 41:203-4.
63. Cappadoro M, Giribaldi G, O'Brien E, Turrini F, Mannu F, Ulliers D, Simula G, Luzzatto L, Arese P. Early phagocytosis of glucose-6- phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998;92:2527-34.
64. Arese P, Turrini F, Schwarzer E. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005;16:133-46.
65. Atkinson SH, Rockett K, Sirugo G, Bejon PA, Fulford A, O'Connell M A, Bailey R, Kwiatkowski DP, Prentice AM. Seasonal Childhood Anaemia in West Africa Is Associated with the Haptoglobin 2-2 Genotype. PLoS Med 2006;3:e172.
66. Cabrera G, Cot M, Migot-Nabias F, Kremsner PG, Deloron P, Luty AJ. The sickle cell trait is associated with enhanced immunoglubin G antibody responses to Plasmodium falciparum variant surface antigens. J Infect Dis 2005;191:1631-8.
67. Williams TN, Mwangi TW, Roberts DJ, Alexander ND, Weatherall DJ, Wambua S, Kortok M, Snow RW, Marsh K. An immune basis for malaria protection by the sickle cell trait. PLoS Med 2005;2:e128.
68. Ayi K, Turrini F, Piga A, Arese P, Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004;104:3364-71.
69. Roberts DJ, Harris T, Williams T. The influence of inherited traits on malaria infection. In: Bellamy R, ed. Susceptibility to infectious diseases: the importance of host genetics. Cambridge: Cambridge University Press; 2004: 139-84.
70. Williams TN, Mwangi TW, Wambua S, Alexander ND, Kortok M, Snow RW, Marsh K. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis 2005;192:178-86.
71. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, Nahlen BL, Lal AA, Udhayakumar V. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 2002;359:1311-2.
72. Williams TN, Mwangi TW, Wambua. S, Peto TE, Weatherall DJ, Gupta S, Recker M, Penman BS, Uyoga S, Macharia A, Mwacharo JK, Snow RW, Marsh K. Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet 2005;37:1253-7.
73. Menendez C, Todd J, Alonso PL, Francis N, Lulat S, Ceesay S, Ascaso C, Smith T, M'Boge B, Greenwood BM. The response to iron supplementation of pregnant women with the haemoglobin genotype AA or AS. Trans R Soc Trop Med Hyg 1995;89:289-92.
74. Terlouw DJ, Desai MR, Wannemuehler KA, Kariuki SK, Pfeiffer CM, Kager PA, Shi YP, Ter Kuile FO. Relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western Kenya. Am J Clin Nutr 2004;79:466-72.
75. Duffy PE, Fried M. Malaria in the pregnant woman. Curr Top Microbiol Immunol 2005;295:169-200.
76. Schellenberg D, Menendez C, Kahigwa E, Aponte J, Vidal J, Tanner M, Mshinda H, Alonso R Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 2001;357:1471-7.
77. Schellenberg D, Menendez C, Aponte JJ, Kahigwa E, Tanner M, Mshinda H, Alonso P. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 2005;365:1481-3.
78. O'Meara WP, Breman JG, McKenzie FE. The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). Malar J 2005;4:33.
79. White NJ. Intermittent presumptive treatment for malaria. PLoS Med 2005;2:e3.
80. Elagib AA, Kider AO, Akerstrom B, Elbashir MI. Association of the haptoglobin phenotype (1-1) with falciparum malaria in Sudan. Trans R Soc Trop Med Hyg 1998;92:309-11.
81. Minang JT, Gyan BA, Anchang JK, Troye-Blomberg M, Perlmann H, Achidi EA. Haptoglobin phenotypes and malaria infection in pregnant women at delivery in western Cameroon. Acta Trop 2004;90:107-14.
82. Quaye IK, Ekuban FA, Goka BQ, Adabayeri V, Kurtzhals JA, Gyan B, Ankrah NA, Hviid L, Akanmori BD. Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 2000;94:216-9.
83. Singh IP, Walter H, Bhasin MK, Bhardwaj V, Sudhakar K. Genetic markers and malaria. Observations in Gujarat, India. Hum Hered 1986;36:31-6.
84. Aucan C, Walley AJ, Greenwood BM, Hill AV. Haptoglobin genotypes are not associated with resistance to severe malaria in The Gambia. Trans R Soc Trop Med Hyg 2002;96:327-8.
85. Bienzle U, Eggelte TA, Adjei LA, Dietz E, Ehrhardt S, Cramer JP, Otchwemah RN, Mockenhaupt FP. Limited influence of haptoglobin genotypes on severe malaria in Ghanaian children. Trop Med Int Health 2005;10:668-71.
86. Takeda M, Kikuchi M, Ubalee R, Na-Bangchang K, Ruangweerayut R, Shibahara S, Imai S, Hirayania K. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to cerebral malaria in Myanmar. Jpn J Infect Dis 2005; 58:268-71.
87. Shankar AH. Nutritional modulation of malaria morbidity and mortality. J Infect Dis 2000;182 Suppl 1: S37-53.
88. Gera T, Sachdev HP. Effect of iron supplementation on incidence of infectious illness in children: systematic review. Bmj 2002;325:1142.